PT973511E - Utilizacao de analogos de sibutramina para baixar os niveis de lipidos - Google Patents
Utilizacao de analogos de sibutramina para baixar os niveis de lipidosInfo
- Publication number
- PT973511E PT973511E PT97910289T PT97910289T PT973511E PT 973511 E PT973511 E PT 973511E PT 97910289 T PT97910289 T PT 97910289T PT 97910289 T PT97910289 T PT 97910289T PT 973511 E PT973511 E PT 973511E
- Authority
- PT
- Portugal
- Prior art keywords
- lipid levels
- sibutramine
- analogs
- download
- utilization
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title abstract 2
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical class C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 title 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 238000008214 LDL Cholesterol Methods 0.000 abstract 1
- UWAOJIWUVCMBAZ-UHFFFAOYSA-N [1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-dimethylazanium;chloride Chemical compound Cl.C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UWAOJIWUVCMBAZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Fats And Perfumes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Analogue/Digital Conversion (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619961.7A GB9619961D0 (en) | 1996-09-25 | 1996-09-25 | Medical treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT973511E true PT973511E (pt) | 2003-08-29 |
Family
ID=10800447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97910289T PT973511E (pt) | 1996-09-25 | 1997-09-15 | Utilizacao de analogos de sibutramina para baixar os niveis de lipidos |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6187820B1 (https=) |
| EP (1) | EP0973511B1 (https=) |
| JP (1) | JP4143126B2 (https=) |
| KR (1) | KR100573333B1 (https=) |
| CN (1) | CN1173696C (https=) |
| AT (1) | ATE239459T1 (https=) |
| AU (1) | AU724645B2 (https=) |
| BG (1) | BG64472B1 (https=) |
| BR (1) | BR9711411A (https=) |
| CA (1) | CA2266378C (https=) |
| CZ (1) | CZ291879B6 (https=) |
| DE (1) | DE69721833T2 (https=) |
| DK (1) | DK0973511T3 (https=) |
| ES (1) | ES2199354T3 (https=) |
| GB (1) | GB9619961D0 (https=) |
| HU (1) | HU224711B1 (https=) |
| IL (1) | IL128820A (https=) |
| NO (1) | NO991424D0 (https=) |
| NZ (1) | NZ334550A (https=) |
| PL (1) | PL190017B1 (https=) |
| PT (1) | PT973511E (https=) |
| RU (1) | RU2197959C2 (https=) |
| SK (1) | SK284282B6 (https=) |
| TR (1) | TR199900648T2 (https=) |
| UA (1) | UA63916C2 (https=) |
| WO (1) | WO1998013034A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| AU2007200334B8 (en) * | 1998-08-24 | 2010-10-21 | Sepracor, Inc. | Methods of using and compositions comprising dopamine reuptake inhibitors |
| US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6046242A (en) * | 1998-11-27 | 2000-04-04 | Basf Aktiengesellschaft | Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| US6696495B2 (en) | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
| US6323242B1 (en) | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
| US6552087B1 (en) | 1999-03-19 | 2003-04-22 | Abbott Gmbh & Co. Kg | Therapeutic agent comprising (+)-sibutramine |
| AU3894500A (en) * | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Prevention of cardiovascular disease |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
| US6610887B2 (en) | 2001-04-13 | 2003-08-26 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| JP4278652B2 (ja) * | 2002-10-05 | 2009-06-17 | ハンミ ファーム． シーオー．， エルティーディー． | 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物 |
| EP1622600A1 (en) * | 2003-04-28 | 2006-02-08 | Cipla Ltd. | Pharmaceutical formulation comprising anti-obesity agent and acidulant |
| US20050032908A1 (en) * | 2003-08-04 | 2005-02-10 | Beckman Kristen M. | Methods for treating metabolic syndrome |
| US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
| KR100618176B1 (ko) | 2004-12-02 | 2006-09-01 | 휴먼팜 주식회사 | 시부트라민 주석산염, 이의 제조 방법 및 이를 포함하는약학적 조성물 |
| KR20060080817A (ko) | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 디카복실산염 |
| WO2006073292A1 (en) * | 2005-01-06 | 2006-07-13 | Cj Corporation | Inorganic acid salts of sibutramine |
| KR20060080818A (ko) * | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 술폰산염 |
| KR20060093564A (ko) * | 2005-02-22 | 2006-08-25 | 종근당바이오 주식회사 | 무수 시부트라민 말산염 및 이의 제조 방법 |
| KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
| KR100814384B1 (ko) * | 2006-02-10 | 2008-03-18 | 대화제약 주식회사 | 시부트라민 염을 함유하는 약학 조성물 및 이의 제조방법 |
| WO2008034142A2 (en) | 2006-09-15 | 2008-03-20 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
| KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
| WO2010082216A2 (en) * | 2008-12-08 | 2010-07-22 | Matrix Laboratories Ltd | Novel salts of sibutramine and their crystal forms |
| RU2642074C2 (ru) | 2011-12-30 | 2018-01-24 | Ревива Фармасьютикалс, Инк. | Композиции, синтез и способы применения производных фенилциклоалкилметиламина |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
| JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
| IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
1996
- 1996-09-25 GB GBGB9619961.7A patent/GB9619961D0/en active Pending
-
1997
- 1997-09-15 SK SK320-99A patent/SK284282B6/sk unknown
- 1997-09-15 DE DE69721833T patent/DE69721833T2/de not_active Expired - Lifetime
- 1997-09-15 CZ CZ1999932A patent/CZ291879B6/cs not_active IP Right Cessation
- 1997-09-15 CA CA002266378A patent/CA2266378C/en not_active Expired - Fee Related
- 1997-09-15 RU RU99108731/14A patent/RU2197959C2/ru active
- 1997-09-15 TR TR1999/00648T patent/TR199900648T2/xx unknown
- 1997-09-15 ES ES97910289T patent/ES2199354T3/es not_active Expired - Lifetime
- 1997-09-15 JP JP51521998A patent/JP4143126B2/ja not_active Expired - Fee Related
- 1997-09-15 CN CNB971982341A patent/CN1173696C/zh not_active Expired - Fee Related
- 1997-09-15 PL PL97332367A patent/PL190017B1/pl not_active IP Right Cessation
- 1997-09-15 AU AU47741/97A patent/AU724645B2/en not_active Ceased
- 1997-09-15 US US09/269,340 patent/US6187820B1/en not_active Expired - Lifetime
- 1997-09-15 EP EP97910289A patent/EP0973511B1/en not_active Expired - Lifetime
- 1997-09-15 IL IL12882097A patent/IL128820A/en not_active IP Right Cessation
- 1997-09-15 NZ NZ334550A patent/NZ334550A/xx not_active IP Right Cessation
- 1997-09-15 KR KR1019997002490A patent/KR100573333B1/ko not_active Expired - Fee Related
- 1997-09-15 UA UA99042290A patent/UA63916C2/uk unknown
- 1997-09-15 WO PCT/EP1997/005040 patent/WO1998013034A1/en not_active Ceased
- 1997-09-15 HU HU9903823A patent/HU224711B1/hu active IP Right Grant
- 1997-09-15 DK DK97910289T patent/DK0973511T3/da active
- 1997-09-15 BR BR9711411A patent/BR9711411A/pt not_active IP Right Cessation
- 1997-09-15 AT AT97910289T patent/ATE239459T1/de not_active IP Right Cessation
- 1997-09-15 PT PT97910289T patent/PT973511E/pt unknown
-
1999
- 1999-03-15 BG BG103249A patent/BG64472B1/bg unknown
- 1999-03-24 NO NO991424A patent/NO991424D0/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT973511E (pt) | Utilizacao de analogos de sibutramina para baixar os niveis de lipidos | |
| ATE232720T1 (de) | Adjuvans für impfstoff | |
| ES2166817T3 (es) | Mejora de la tolerancia a la glucosa. | |
| PT100673A (pt) | Processo para a preparacao de intermediarios de sertralina e compostos assim obtidos | |
| DK1461306T3 (da) | Kvaternære ammoniumforbindelser og deres anvendelse som antimuscarin-midler | |
| BR0002073A (pt) | Processo para a preparação de um composto quiral | |
| BR0311193A (pt) | Aduto de topiramato e cloridrato de tramadol e usos dos mesmos | |
| CA2520128A1 (en) | Process for the preparation of n-substituted 2-cyanopyrrolidines | |
| NO20031439L (no) | Agrokjemisk blanding som inneholder aktivitetsstyrkende hjelpestoffer | |
| PT1007023E (pt) | Derivados de 1-¬1-(4-clorofenil)ciclobutil|-3-metil-butil amina para reducao dos niveis de acido urico em seres humanos | |
| BR9607809A (pt) | Suportes isoladores de vibração para uma ferramenta pneumática | |
| BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
| BR0214742A (pt) | Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação | |
| BR0115616A (pt) | Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1 | |
| DK1169029T3 (da) | Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser | |
| BR9908970A (pt) | Processo para a preparação do composto, e, composto | |
| KR960037677A (ko) | 4-인돌릴피페라지닐 유도체 | |
| EE200200583A (et) | (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod | |
| BRPI9809153A (pt) | composto, processo para a preparação da 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihidroxipropil)-isoftalamida, e, uso da mesma | |
| BR0116721A (pt) | Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina | |
| BR0115019A (pt) | Composições sólidas adequadas para administração oral contendo sais não-higroscópicos de l-carnitina e as l-carnitinas e alcanoìla com cloreto de taurina e cloreto de glicina | |
| HK1045254A1 (zh) | 降低血小板黏性的处理方法 | |
| BR8602721A (pt) | Processo para a preparacao de derivados de benzaldoxima-carbamato,composicoes pesticidas,processos para o combate de pestes e para a preparacao de composicoes | |
| CA2235053A1 (fr) | Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta¬a|naphtalene et du 2,3-dihydro-cyclopenta, ¬e|indene, leur procede de preparation et les compositions pharmaceutiques quiles contiennent | |
| TR200200949T2 (tr) | Polimorfik N-[3-[[2-(3,4-dimetoksifenil)etil]amino]propil]-4-nitro benzamid hidroklorid |